HeartBeam, Inc. (BEAT) |
| 2.4 -0.16 (-6.25%) 01-13 16:00 |
| Open: | 2.49 |
| High: | 2.49 |
| Low: | 2.305 |
| Volume: | 1,139,431 |
| Market Cap: | 82(M) |
| PE Ratio: | -3.64 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Medical - Healthcare Information Services |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 4.67 |
| Resistance 1: | 4.00 |
| Pivot price: | 2.51 |
| Support 1: | 1.98 |
| Support 2: | 0.73 |
| 52w High: | 4 |
| 52w Low: | 0.54 |
HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.
| EPS | -0.660 |
| Book Value | 0.010 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | -272.4 |
| Return on Equity (ttm) | -792.0 |
Fri, 09 Jan 2026
FDA Clearance for HeartBeam (BEAT) Highlighted in Medical Device Approvals Roundup - NewMediaWire
Fri, 09 Jan 2026
About Us - FinancialContent
Mon, 05 Jan 2026
HeartBeam (BEAT) to Attend JP Morgan 2026 Annual Healthcare Conference - NewMediaWire
Mon, 05 Jan 2026
HeartBeam to Attend JP Morgan 2026 Annual Healthcare Conference - Business Wire
Thu, 25 Dec 2025
HeartBeam Stock Slumps After FDA Refuses Clearance For ECG Software - MSN
Thu, 18 Dec 2025
HeartBeam (BEAT) Ranks Second Worldwide in 12-Lead ECG Innovation - Yahoo Finance
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |